• 1. An integrated droplet-digital microfluidic system for on-demand droplet creation, mixing, incubation, and sorting?
  Lab Chip, 2019,19, 524-535
• 2. An analyte-triggered artificial peroxidase system based on dimanganese complex for a versatile enzyme assay?
  Suji Lee,Min Su Han Chem. Commun., 2021,57, 9450-9453
• 3. An approach towards the synthesis of novel fused nitrogen tricyclic heterocyclic scaffolds via GBB reaction?
  Sandip Gangadhar Balwe,Yeon Tae Jeong Org. Biomol. Chem., 2018,16, 1287-1296
• 4. An intermolecular C–H oxidizing strategy to access highly fused carbazole skeletons from simple naphthylamines?
  Christian K. Rank,Alexander W. Jones,Tatjana Wall,Patrick Di Martino-Fumo,Sarah Schr?ck,Markus Gerhards,Frederic W. Patureau Chem. Commun., 2019,55, 13749-13752
• 5. An antimonate pyrochlore (H1.23Sr0.45SbO3.48) for photocatalytic oxidation of benzene: effective oxygen usage and excellent activity?
  Jing Chen,Yu Shao,Danzhen Li J. Mater. Chem. A, 2017,5, 937-941

Professional Introduction to N-(3-methylphenyl)methylhydroxylamine (CAS No. 112997-83-8)

N-(3-methylphenyl)methylhydroxylamine, a compound with the CAS number 112997-83-8, is a specialized organic molecule that has garnered significant attention in the field of pharmaceutical chemistry and bioorganic research. This compound, characterized by its unique structural and functional properties, serves as a valuable intermediate in the synthesis of various pharmacologically active agents. The presence of a hydroxylamine functional group and a methyl-substituted aromatic ring makes it particularly intriguing for researchers exploring novel therapeutic avenues.

The chemical structure of N-(3-methylphenyl)methylhydroxylamine consists of a benzene ring substituted with a methyl group at the 3-position, attached to a hydroxylamine moiety through a methylene bridge. This configuration imparts distinct electronic and steric properties to the molecule, making it a versatile building block in medicinal chemistry. The hydroxylamine group is known for its reactivity, particularly in nucleophilic substitution reactions, while the aromatic ring enhances lipophilicity and metabolic stability, crucial factors in drug design.

In recent years, N-(3-methylphenyl)methylhydroxylamine has been extensively studied for its potential applications in the development of novel drugs targeting various diseases. One of the most promising areas of research involves its use as a precursor in the synthesis of kinase inhibitors. Kinases are enzymes that play a critical role in cell signaling pathways, and their dysregulation is implicated in numerous cancers and inflammatory diseases. By designing molecules that selectively inhibit specific kinases, researchers aim to develop treatments that can modulate these pathways effectively.

Recent studies have highlighted the compound's utility in generating highly potent and selective kinase inhibitors. For instance, derivatives of N-(3-methylphenyl)methylhydroxylamine have been shown to exhibit inhibitory activity against tyrosine kinases, which are overactive in many forms of cancer. The hydroxylamine group allows for facile modifications, enabling chemists to fine-tune the pharmacokinetic properties of these inhibitors. This flexibility has led to the discovery of several lead compounds that are currently undergoing preclinical evaluation.

Another significant application of N-(3-methylphenyl)methylhydroxylamine lies in its role as an intermediate in the synthesis of antiviral agents. Viruses rely on host cellular machinery for replication, and inhibiting key viral enzymes can disrupt their life cycle. Researchers have leveraged the reactivity of the hydroxylamine group to develop compounds that target viral proteases and polymerases. These efforts have resulted in several promising candidates that show efficacy against both RNA and DNA viruses, offering hope for new treatments against emerging infectious diseases.

The compound's structural features also make it valuable in the development of neuroprotective agents. Neurodegenerative diseases such as Alzheimer's and Parkinson's are characterized by the aggregation of misfolded proteins and oxidative stress. N-(3-methylphenyl)methylhydroxylamine-based molecules have been investigated for their ability to inhibit protein aggregation and scavenge reactive oxygen species. Preliminary findings suggest that these compounds can protect neuronal cells from damage caused by oxidative stress, potentially leading to novel therapeutic strategies for these debilitating conditions.

From a synthetic chemistry perspective, N-(3-methylphenyl)methylhydroxylamine serves as a versatile scaffold for exploring new reaction pathways and methodologies. Its unique reactivity allows chemists to develop innovative synthetic routes that may be applicable to other complex molecules. The compound's stability under various reaction conditions makes it an ideal candidate for library synthesis programs aimed at generating large collections of diverse compounds for high-throughput screening.

The pharmaceutical industry has taken notice of the potential of N-(3-methylphenyl)methylhydroxylamine as a building block for drug discovery. Several major pharmaceutical companies have included this compound in their internal libraries, recognizing its versatility and utility across multiple therapeutic areas. Collaborative research initiatives between academic institutions and industry partners continue to explore new applications for this compound, further solidifying its importance in modern medicinal chemistry.

In conclusion, N-(3-methylphenyl)methylhydroxylamine (CAS No. 112997-83-8) is a multifaceted compound with significant potential in pharmaceutical research and drug development. Its unique structural features and reactivity make it an invaluable tool for designing novel therapeutics targeting cancers, viruses, neurodegenerative diseases, and other disorders. As research continues to uncover new applications for this compound, its importance is likely to grow even further, shaping the future landscape of medicinal chemistry.

• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)